◀ Back to NFKB1
CLU — NFKB1
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Saura et al., J Neurochem 2003
:
Two
NF-kappa B inhibitors, aspirin ( 10 mM ) and MG-132 ( 0.1 microM ),
blocked basal apoE and
apoJ secretion as well as LPS induced apoJ secretion
Santilli et al., J Biol Chem 2003
(Neoplasm Invasiveness) :
Ectopic
apolipoprotein J expression strongly
inhibited NF-kappaB activity in human neuroblastoma cells and murine embryonic fibroblasts by stabilizing inhibitors of NF-kappaB ( IkappaBs )
Devauchelle et al., J Immunol 2006
(Arthritis, Rheumatoid...) :
We propose that in RA joints, high levels of extracellular
CLU and low expression of intracellular CLU may
enhance NF-kappaB activation and survival of the synoviocytes
Savković et al., Biochem Biophys Res Commun 2007
(Disease Models, Animal...) :
Presence of
clusterin reduced
NF-kappaB activation and expression of the NF-kappaB target genes TNF-alpha and MOB-1 under cell stress